Camcevi (Leuprolide)

Camcevi (leuprolide) is a gonadotropin-releasing hormone (GnRH) agonist used for the treatment of adult patients with advanced prostate cancer.

Recommended Dosage:
The recommended dose of Camcevi injectable emulsion is given as a 42 mg dose every 6 months. It is administered as a subcutaneous (SC) injection, which means it is injected just under the skin. This long-acting therapy is designed to release the medicine slowly over 6 months. It helps reduce the number of injections required. It is commonly used for the management of advanced prostate cancer. Patients should follow their healthcare professional’s schedule and not miss any dose to ensure effective treatment and consistent outcomes.

• Treatment with Leuprolide may cause an initial surge in hormone levels. This may lead to tumor flare in prostate cancer patients. Symptoms like bone pain or urinary obstruction may worsen temporarily. Close monitoring is required, especially in those with metastases to the spine or urinary tract obstruction.
• The use of Leuprolide 42 mg injectable emulsion is associated with elevated blood glucose, leading to new diabetes or the worsening of diabetes. Regular monitoring of blood glucosylated HbA1c levels should be done. Attention must be paid to diabetic patients undergoing treatment to maintain control of blood sugar.
• Leuprolide increases the risk of an ischemic heart event, including myocardial infarction, death, or stroke. Other patients with known cardiovascular diseases should be very closely monitored. Significant reduction of treated cardiac risk factors should be required during this therapy.
• Reports of using GnRH agonists such as leuprolide have shown prolongation of QT and QTc intervals. Those with a susceptible long QT syndrome or patients on drugs that prolong the QT interval should be monitored with ECG and electrolytes for potential deadly arrhythmias.
  Seizures have been reported in patients using leuprolide, even in those who do not have a seizure history. Special care is recommended for patients with factors that may lower the seizure threshold. If any seizures, spasms, or atypical gestures happen during therapy, immediate assessment is necessary.
  Depending on the change of treatment response and the hormone levels, periodic blood sampling might be necessary. Moreover, evaluation of liver and kidney functions should be done from time to time. PSA levels in men undergoing treatment are also needed to assess the utility of this medicine in controlling prostate cancer.
• Leuprolide 42 mg injectable emulsion should be avoided during pregnancy since it may lead to pregnancy loss or fetal destruction. Women wishing to get pregnant should use optimal safe contraception while on treatment. Before beginning the therapy, it is necessary to conduct a test to rule out any existing pregnancy.
• It remains unclear whether leuprolide is excreted into breast milk. However, due to the plausible harms to the infant, breastfeeding during treatment should be avoided. Women should be recommended to give up breastfeeding or avoid leuprolide, depending on the importance of the drug.

What documents are required to import CAMCEVI to India?

CAMCEVI (leuprolide) injectable emulsion can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:
A valid prescription from a qualified doctor.

• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is CAMCEVI available in India?

CAMCEVI (leuprolide injectable emulsion) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On availability of Camcevi in India (Mumbai, Kolkata,
• Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar,
• Kuwait, Iraq, Saudi Arabia, and the UAE).
• Medicine Price.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

CAMCEVI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of CAMCEVI (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Camcevi 42 mg injection price in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source CAMCEVI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient's address only from New Delhi, India.

What is the Generic Name for the trade name drug Camcevi®?

Leuprolide is the Generic Name for the trade name drug Camcevi®.

What is the Manufacturer's Name of Camcevi®?

Camcevi® is manufactured by Foresee Pharmaceuticals.

What is the dosage and form of Camcevi® supplied?

Camcevi is supplied in an Injectable emulsion: 42 mg for subcutaneous (SC) use.

What are the most common side effects of Camcevi® 42 mg injectable emulsion?

The most common side effects of Camcevi® are injection site reactions, hot flushes, hypertension, fatigue, pain in extremities, upper respiratory tract infections, musculoskeletal pain, arthralgia, nocturia, micturition urgency, and dizziness.

How much does Camcevi® 42 mg injection cost in India?

Prices of Camcevi injectable emulsion may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Camcevi 42 mg cost in India, please call/WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

Can Camcevi® 42 mg injections be available in SAARC countries?

Apart from Gulf countries, Camcevi® can be available in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Camcevi® injectable emulsion in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Camcevi® 42 mg injectable emulsion online in India?

Yes, one can buy Camcevi 42 mg online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the legal supply of Camcevi® injectable emulsion through legal channels.

What are the storage conditions of Camcevi® 42 mg injections?

Store this therapeutic drug at 2°C to 8°C (36°F to 46°F). Protect it from light by storing it in the original package until the time of use. It is not advisable to freeze or shake this medicine.